Amneal Pharmaceuticals Inc (AMRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Chintu Patel
Employees:
7,000
400 Crossing Boulevard, Bridgewater, NJ
(908) 947-3120

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products. The company operates through three segments: Generics, Specialty, and AvKARE. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.

Data derived from most recent annual or quarterly report
Market Cap 476.551 Million Shares Outstanding150.807 Million Avg 30-day Volume 981.404 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.15
Price to Revenue0.2262 Debt to Equity14.859 EBITDA124.59 Million
Price to Book Value1.7128 Operating Margin-6.389799999999999 Enterprise Value3.129 Billion
Current Ratio1.565 EPS Growth-18.6 Quick Ratio0.788
1 Yr BETA 0.8972 52-week High/Low 5.99 / 2.88 Profit Margin-12.8667
Operating Cash Flow Growth-43.1225 Altman Z-Score0.5274 Free Cash Flow to Firm -114.831 Million
View SEC Filings from AMRX instead.

View recent insider trading info

Funds Holding AMRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-19:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-01-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    23.1 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    AUTOR DEBORAH M.

    • Director
    0 2022-07-29 2

    BOYER ANDREW S EXECUTIVE VICE PRESIDENT

    • Officer
    231,191 2022-06-30 4

    MEISTER PAUL M

    • Director
    620,658 2022-05-08 1

    BUCHI J KEVIN

    • Director
    185,619 2022-05-08 1

    NARK TED C

    • Director
    224,318 2022-05-08 1

    YANAI SHLOMO

    • Director
    169,274 2022-05-08 1

    PATEL GAUTAM

    • Director
    13,261,751 2022-05-08 2

    ALVA EMILY PETERSON

    • Director
    174,318 2022-05-08 1

    KIELY JOHN

    • Director
    179,274 2022-05-08 1

    GEORGE JEFFREY P.

    • Director
    193,084 2022-05-08 1

    SHAH NIKITA EXECUTIVE VICE PRESIDENT

    • Officer
    267,308 2022-05-07 4

    TODISCO JOSEPH EXECUTIVE VICE PRESIDENT

    • Officer
    327,194 2022-05-07 4

    KONIDARIS TASOS EXECUTIVE VICE PRESIDENT & CFO

    • Officer
    387,074 2022-03-12 2

    PATEL CHINTU CO-CEO

    • Officer
    • Director
    1,159,420 2022-03-03 2

    PATEL CHIRAG K. PRESIDENT & CO-CEO

    • Officer
    • Director
    • 10% Owner
    1,159,420 2022-03-03 2

    DALY JASON B. SVP, CHIEF LEGAL OFFICER

    • Officer
    271,740 2022-03-03 2

    TPG GP A, LLC

    WINKELRIED JON

    • 10% Owner
    16,213,367 2022-01-12 1

    MANZANO STEPHEN SVP, GENERAL COUNSEL

    • Officer
    202,704 2021-03-01 0

    TERRERI PETER R

    • Director
    No longer subject to file 2020-05-04 0

    BRANNING TODD P. SVP AND CFO

    • Officer
    0 2020-02-27 0

    BUCHEN DAVID A SVP, CHIEF LEGAL OFFICER

    • Officer
    20,426 2020-01-03 0

    BHADAURIA PRADEEP SVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2019-11-13 0

    FOSUN INTERNATIONAL LTD

    • 10% Owner
    18,407,656 2019-08-06 0

    TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

    BONDERMAN DAVID

    COULTER JAMES G

    • 10% Owner
    16,213,367 2019-07-18 0

    BISARO PAUL EXECUTIVE CHAIRMAN

    • Officer
    • Director
    29,454 2019-05-07 0

    STEWART ROBERT A PRESIDENT AND CEO

    • Officer
    • Director
    78,668 2019-05-07 0

    BURR ROBERT L

    • Director
    102,639 2019-05-06 0

    VERGIS JANET S.

    • Director
    18,257 2019-05-06 0

    GREENE JEAN SELDEN

    • Director
    6,107 2019-05-06 0

    RAMA DHARMENDRA

    • Director
    6,107 2019-05-06 0

    KNAPP COURTNEY J VICE PRESIDENT

    • Officer
    • Director
    1,499,450 2009-06-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    AUTOR DEBORAH M. - Director

    2022-08-02 21:26:39 -0400 2022-07-29 A 54,949 a 54,949 direct

    BOYER ANDREW S - Officer EXECUTIVE VICE PRESIDENT

    2022-07-05 12:15:34 -0400 2022-06-30 M 23,094 a 219,678 direct -3.012 -4.5181 0.0 1 -4.5181 6

    BOYER ANDREW S - Officer EXECUTIVE VICE PRESIDENT

    2022-07-05 12:15:34 -0400 2022-06-30 F 11,582 $3.18 d 208,096 direct -3.012 -4.5181 0.0 1 -4.5181 6

    BOYER ANDREW S - Officer EXECUTIVE VICE PRESIDENT

    2022-07-05 12:15:34 -0400 2022-06-30 M 23,094 d 23,095 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 22:15:03 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 21:45:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 21:15:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 20:45:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 20:15:05 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 19:45:03 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 19:15:05 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 18:45:03 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 18:15:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 17:45:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 17:15:05 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 16:45:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 16:15:04 UTC 1.6826 0.6374 7400000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 15:45:04 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 15:15:05 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 14:45:04 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 14:15:05 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 13:45:04 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 13:15:04 UTC 1.6826 0.6374 7200000
    AMNEAL PHARMACEUTICALS INC AMRX 2022-08-12 12:45:04 UTC 1.6826 0.6374 7200000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund AMRX -1045.0 shares, $-3636.6 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund AMRX -174.0 shares, $-605.52 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund AMRX -676.0 shares, $-2352.48 2020-03-31 N-PORT
    Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.58% 2018-06-13 GERMANY

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin
    Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.54% 2018-05-23 GERMANY
    Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.63% 2018-05-25 GERMANY

    Elevate your investments